Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 00:10:43 UTC 2023
by
admin
on
Sat Dec 16 00:10:43 UTC 2023
|
Protein Type | MONOCLONAL ANTIBODY |
Protein Sub Type | IGG4 |
Sequence Origin | HUMANIZED MOUSE |
Sequence Type | COMPLETE |
Record UNII |
LT369U66CE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
J05AX23
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
||
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
70692
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
||
|
FDA ORPHAN DRUG |
321910
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Hexamethylphosphoramide
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
SUB130719
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
ALTERNATIVE | |||
|
LT369U66CE
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
100000168847
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
DB12698
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
SUB182421
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
CHEMBL1743029
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
LT369U66CE
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
2043313
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
ALTERNATIVE | |||
|
Ibalizumab
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
m12068
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
5279
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
C88612
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
680188-33-4
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
2043283
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
8818
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
DTXSID601028049
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY | |||
|
SS-01
Created by
admin on Sat Dec 16 00:10:43 UTC 2023 , Edited by admin on Sat Dec 16 00:10:43 UTC 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
1_136 | 3_219 |
1_149 | 1_205 |
1_228 | 2_228 |
1_231 | 2_231 |
1_263 | 1_323 |
1_369 | 1_427 |
2_22 | 2_96 |
2_136 | 4_219 |
2_149 | 2_205 |
2_263 | 2_323 |
2_369 | 2_427 |
3_23 | 3_94 |
3_139 | 3_199 |
4_23 | 4_94 |
4_139 | 4_199 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Blocks HIV infection. Used against MDR HIV Strains
|
||
|
INNOVATOR->PARENT | |||
|
SUB_CONCEPT->SUBSTANCE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:ESTIMATED | CHEMICAL |
|
||||
Biological Half-life | PHARMACOKINETIC |
|
|
|||